1. Home
  2. PODD vs NEU Comparison

PODD vs NEU Comparison

Compare PODD & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insulet Corporation

PODD

Insulet Corporation

N/A

Current Price

$141.19

Market Cap

10.2B

Sector

Health Care

ML Signal

N/A

Logo NewMarket Corp

NEU

NewMarket Corp

N/A

Current Price

$889.97

Market Cap

8.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PODD
NEU
Founded
2000
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
8.6B
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
PODD
NEU
Price
$141.19
$889.97
Analyst Decision
Buy
Analyst Count
21
0
Target Price
$341.48
N/A
AVG Volume (30 Days)
1.6M
95.0K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
1.79%
EPS Growth
N/A
N/A
EPS
2.67
27.14
Revenue
$2,708,100,000.00
$2,725,169,000.00
Revenue This Year
$24.55
N/A
Revenue Next Year
$19.18
N/A
P/E Ratio
$52.15
$32.59
Revenue Growth
30.73
N/A
52 Week Low
$126.40
$580.03
52 Week High
$354.88
$981.66

Technical Indicators

Market Signals
Indicator
PODD
NEU
Relative Strength Index (RSI) 43.01 48.14
Support Level $126.40 $629.50
Resistance Level $153.33 $981.66
Average True Range (ATR) 4.92 22.92
MACD -0.57 -7.19
Stochastic Oscillator 39.49 49.29

Price Performance

Historical Comparison
PODD
NEU

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

About NEU NewMarket Corp

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives used in lubricating oils and fuels to enhance performance. The company operates through two segments: petroleum additives, mainly represented by Afton, where lubricant additives improve the efficiency and durability of base fluids and fuel additives help meet fuel specifications and improve fuel performance, and specialty materials, represented by AMPAC and Calca, including the antiknock compounds business of Ethyl, where primary raw materials include electricity, sodium chlorate, ammonia, chlorine, caustic, and hydrochloric acid, with graphite used in electrolytic cells. The company has operations in North America, Latin America, Asia Pacific, and EMEAI regions.

Share on Social Networks: